Biomarkers in Cluster Headache. A systematic review.

Current Status
Not Enrolled
Get Started


To systematically investigate previously examined biomarkers in blood, urine, cerebrospinal fluid, tear-fluid, and saliva of patients with cluster headache.

Activity Disclosures 

No commercial support has been accepted related to the development or publication of this activity.

Marie-Louise Kulas Søborg is a current sub-investigator in trials for Lundbeck (trials: 19385A and 19386A). Mads Christian Johannes Barløse has no conflict of interest to report. Rigmor Højland Jensen has served and serves as principal investigator in studies sponsored by Eli Lily, Novartis, Autonomic Technologies (ATI) and Lundbeck and has given lectures for Eli-Lily, ATI, Lundbeck, Novartis, Allergan (AbbVie), Pfizer, Berlin-Chemie, Norspan, Merck, and TEVA. Anja Sofie Petersen has received personal fees from Pfizer for teaching activities, a restricted research grant by Lundbeck Pharma, and is a current sub-investigator in a trial for Lundbeck (trials: 19385A and 19386A).

This activity underwent peer review in line with standards of editorial integrity and publication ethics. Conflicts of interest have been identified and resolved in accordance with John Wiley and Sons, Inc.’s Policy on Activity Disclosure and Conflict of Interest.

John Wiley & Sons, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

John Wiley and Sons, Inc. designates this journal-based CME activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity. For information on applicability and acceptance of continuing medical education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within 1 hour. To successfully earn credit, participants must access and complete the activity during the valid credit period, which is up to two years from initial publication. Additionally, up to 3 attempts and a score of 70% or better is needed to pass the post test.

Link to content: Biomarkers in cluster headache: A systematic review - Søborg - 2024 - Headache: The Journal of Head and Face Pain - Wiley Online Library

Subscription access to Headache: The Journal of Head and Face Pain is required for article content not under Open Access license.

AHS members may access the journal through their membership portal. Please visit the American Headache Society website for more information on becoming a member.